Low Dose Naltrexone (LDN) for Chronic Pain
Low dose naltrexone (LDN) is one of the most intriguing and under-utilized treatments in chronic pain medicine. While naltrexone at standard doses (50 mg/day) is FDA-approved to treat opioid and alcohol dependence, at a fraction of that dose — typically 1.5 to 4.5 mg taken at bedtime — it produces a completely different biological effect that may substantially reduce inflammation and chronic pain.
Dr. Edward Rubin offers LDN as part of his commitment to non-opioid, evidence-informed pain management. For the right patient, LDN can be a meaningful part of a comprehensive pain treatment plan.
The Science Behind LDN
Standard-dose naltrexone blocks opioid receptors continuously. At low doses taken at night, LDN produces a brief, partial opioid receptor blockade during sleep hours. The body responds by temporarily "upregulating" — increasing — its production of endorphins (the body's own opioid-like molecules) and enkephalins.
The second mechanism may be even more important: LDN appears to directly inhibit microglia — the immune cells of the central nervous system that play a central role in neuroinflammation. Overactivation of microglia is now understood to be a major driver of chronic pain, fibromyalgia, and many autoimmune-related pain conditions.
By calming microglial activity and boosting endogenous opioid tone, LDN works through mechanisms that are fundamentally different from any other pain medication — making it useful precisely in cases where conventional approaches have failed.
Conditions That May Benefit from LDN
LDN has been studied — and used clinically — for a range of conditions:
- Fibromyalgia — Small but well-designed trials show significant pain reduction and improved quality of life
- Complex Regional Pain Syndrome (CRPS) — Case reports and clinical experience support use in this neuroinflammatory condition
- Chronic neuropathic pain — Including post-surgical and post-traumatic neuropathy
- Inflammatory arthritis — Including rheumatoid arthritis and psoriatic arthritis (often used alongside rheumatologic treatment)
- Inflammatory bowel disease — Crohn's disease and ulcerative colitis; strong evidence base
- Multiple sclerosis — Used for fatigue and pain; clinical trials ongoing
- Autoimmune-related pain conditions — Lupus, Sjögren's syndrome, and related conditions
Dr. Rubin will assess whether LDN is appropriate based on your specific diagnosis, prior treatments, and current medication list.
What to Expect with LDN Treatment
Starting dose: LDN is typically started at 1.5 mg at bedtime and gradually increased over several weeks to the therapeutic range of 3–4.5 mg. Slow titration minimizes the chances of sleep disturbance during early treatment.
Timing: LDN is taken at bedtime (typically between 9 PM and midnight) to coincide with the body's peak endorphin production cycle.
When to expect results: Some patients notice improvement within 4–6 weeks. Others require 3–6 months at therapeutic doses to experience meaningful benefit. Unlike many pain medications, the effects tend to build gradually rather than appearing immediately.
Formulation: LDN is not commercially available in the low-dose form needed. It is obtained through a compounding pharmacy that prepares the capsules or liquid formulation in the prescribed dose. Our office will provide a prescription and recommend a reliable compounding pharmacy.
Safety and Side Effects
LDN has an excellent safety profile. The most commonly reported side effects — particularly during the initial titration period — are:
- Vivid or unusual dreams
- Mild sleep disturbance (usually transient, resolves within 1–2 weeks)
- Temporary increase in pain as the body adjusts ("flare" during early treatment)
LDN does not cause the cognitive side effects, constipation, dependence, or hormonal disruption associated with opioids. It has no addiction potential.
Important: If you are currently taking opioid medications, LDN cannot be prescribed alongside them, as it will precipitate withdrawal. If opioid taper is appropriate for your situation, Dr. Rubin will discuss a transition plan.
LDN and Opioid-Free Pain Management
LDN represents an important tool in Dr. Rubin's philosophy of non-opioid, interventional-first pain management. For patients who have tried multiple medications without success, LDN offers a mechanism that nothing else targets — neuroinflammation — often providing the missing piece in a complex pain puzzle.
Frequently Asked Questions
Is LDN FDA-approved for chronic pain? LDN is used off-label for chronic pain. The standard-dose form (50 mg) is FDA-approved for opioid/alcohol dependence. The off-label use of LDN in pain medicine is supported by growing clinical evidence and widespread use among pain specialists.
Does insurance cover LDN? Because it is compounded and off-label, LDN is typically not covered by insurance. The cost at most compounding pharmacies is modest — usually $30–60 per month — making it accessible as a self-pay treatment.
How long do I need to stay on LDN? Most patients who respond well remain on LDN indefinitely, as the benefits typically continue as long as the medication is taken. Unlike opioids, there is no evidence of tolerance or decreasing effectiveness over time.
Can LDN be used with other pain treatments? Yes. LDN works well alongside physical therapy, interventional procedures, anti-inflammatory medications, and other non-opioid medications. It is often used as one component of a multi-modal pain management approach.
Request a Consultation
To find out whether LDN may be appropriate for your chronic pain condition, call our office at 516-492-3100 or request a consultation below. Dr. Rubin will review your history and discuss whether LDN fits into your overall treatment plan.